Bay Area startup TRexBio has bolstered its 2024 Series B with an additional $50 million to fund the biotech’s clinical development in the burgeoning Treg space.
The biotech, founded in 2018 by SV Health Investors …
Takeda’s incoming CEO took a firm stance against President Donald Trump’s “most favored nation” deals with drugmakers on Thursday, while Sanofi and Roche shared new
The White House is punting the launch of TrumpRx, the administration’s hub for direct-to-consumer websites run by large drugmakers. The event was expected to take
Sanofi CEO Paul Hudson emphasized the company’s commitment to vaccine development in the face of an increasingly challenging sales environment and its decision to abandon
Last week, the House Judiciary Committee came out with a report about CVS Health’s alleged antitrust behavior toward disruptive pharmacy models that provide digital services
✂️ Sanofi culls several programs: The move comes as part of its “regular portfolio reviews,” a spokesperson said in an email. One candidate affected was
Bay Area startup TRexBio has bolstered its 2024 Series B with an additional $50 million to fund the biotech’s clinical development in the burgeoning Treg space.
The biotech, founded in 2018 by SV Health Investors …